Epigenetic Markers May Show Which Type 2 Diabetes Patients Can Tolerate Metformin

Home  »  Digital Assets  »   Epigenetic Markers May Show Which Type 2 Diabetes Patients Can Tolerate Metformin

Researchers are learning how to improve the use of metformin from epigenetics. Read on to learn all about these groundbreaking results. 

RELATED: Senolytics Fights Age-Related Diseases In First Human Clinical Trial

In this article:

Type 2 Diabetes Problems with Metformin First Diabetes Pharmacoepigenetic Study Biomarkers for Metformin The Future of Diabetes Management

New Study Alert: Metformin and Epigenetics
Type 2 Diabetes 

The Centers for Disease Control and Prevention (CDC) reports that approximately 1 in 10 Americans have diabetes. Of the

Click HERE to read the full atricle on the TruDiagnostic Forum Blog.